HKSE - Delayed Quote HKD
InnoCare Pharma Limited (9969.HK)
10.140
-0.380
(-3.61%)
At close: April 25 at 4:08:21 PM GMT+8
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 530.96M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Zhao (Renbin) Director (Executive) | -- | Direct | -- | Jan 14, 2025 |
| Shi (Yigong) Director (Non-Executive) | -- | Direct | -- | Jan 14, 2025 |
| Cui (Jisong) Chief Executive Officer | -- | Direct | -- | May 30, 2024 |
| Shi (Yigong) Director (Non-Executive) | -- | Direct | -- | Apr 8, 2024 |
| Zhao (Renbin) Director (Executive) | -- | Direct | -- | Apr 8, 2024 |
| Shi (Yigong) Director (Non-Executive) | -- | Direct | -- | Dec 27, 2023 |
| Zhang (Zemin Jason) Independent Non-Executive Director | -- | Direct | -- | Jul 7, 2023 |
| Cui (Jisong) Chief Executive Officer | -- | Direct | -- | Jan 17, 2023 |
| Zhao (Renbin) Director (Executive) | -- | Direct | -- | Jan 17, 2023 |
| Cui (Jisong) Chief Executive Officer | -- | Direct | -- | Nov 22, 2022 |
| Zhang (Zemin Jason) Independent Non-Executive Director | -- | Direct | -- | Mar 26, 2022 |
| Zhang (Zemin Jason) Independent Non-Executive Director | -- | Direct | -- | Mar 26, 2022 |
| Zhao (Renbin) Director (Executive) | -- | Direct | -- | Mar 1, 2022 |
| Yuan (Quanhong) Director (Non-Executive) | -- | Indirect | -- | Feb 8, 2022 |
| Cui (Jisong) Chief Executive Officer | -- | Direct | -- | Jan 21, 2022 |
| Cui (Jisong) Chief Executive Officer | -- | Direct | -- | Oct 5, 2021 |
| Zhao (Renbin) Director (Executive) | -- | Direct | -- | Oct 5, 2021 |
| Yuan (Quanhong) Director (Non-Executive) | Sale at price 3.73 per share. | Direct | 1,134,612 | Jul 22, 2021 |
| Yuan (Quanhong) Director (Non-Executive) | Sale at price 3.78 per share. | Direct | 5,542,727 | Jul 21, 2021 |
| Yuan (Quanhong) Director (Non-Executive) | Sale at price 3.81 per share. | Direct | 2,285,940 | Jul 20, 2021 |
| Yuan (Quanhong) Director (Non-Executive) | Sale at price 4.02 per share. | Direct | 6,273,190 | Jul 19, 2021 |
| Yuan (Quanhong) Director (Non-Executive) | -- | Direct | -- | Jul 16, 2021 |
| Yuan (Quanhong) Director (Non-Executive) | Sale at price 3.64 per share. | Direct | 364,350 | Jul 9, 2021 |
| Yuan (Quanhong) Director (Non-Executive) | Sale at price 3.61 per share. | Direct | 360,520 | Jul 6, 2021 |
| Yuan (Quanhong) Director (Non-Executive) | Acquisition at price 3.17 per share. | Direct | 20,406,768 | Jun 23, 2021 |
| Yuan (Quanhong) Director (Non-Executive) | Sale at price 3.28 per share. | Direct | 20,945,834 | Jun 23, 2021 |
| Yuan (Quanhong) Director (Non-Executive) | Sale at price 3.20 per share. | Direct | 256,296 | Jun 17, 2021 |
| Yuan (Quanhong) Director (Non-Executive) | Sale at price 3.41 per share. | Direct | 511,935 | Jun 15, 2021 |
| Yuan (Quanhong) Director (Non-Executive) | -- | Direct | -- | Jun 10, 2021 |
| Zhang (Zemin Jason) Independent Non-Executive Director | -- | Direct | -- | Jan 14, 2021 |
| Zhao (Renbin) Director (Executive) | -- | Direct | -- | Jan 14, 2021 |
| Cui (Jisong) Chief Executive Officer | -- | Direct | -- | Jan 14, 2021 |
| Yuan (Quanhong) Director (Non-Executive) | -- | Direct | -- | Jun 22, 2020 |
| Yuan (Quanhong) Director (Non-Executive) | -- | Direct | -- | Mar 20, 2020 |
Related Tickers
1877.HK JUNSHI BIO
15.420
-3.50%
9966.HK Alphamab Oncology
6.910
-0.43%
2142.HK HBM Holdings Limited
8.210
+3.40%
1952.HK Everest Medicines Limited
47.400
+2.16%
473A.F Adaptimmune Therapeutics plc
0.2180
+15.34%
6978.HK Immunotech Biopharm Ltd
4.150
+1.97%
6660.HK AIM Vaccine Co., Ltd.
3.290
-2.95%
1672.HK ASCLETIS-B
6.280
-6.69%
2105.HK Laekna, Inc.
13.660
-6.18%
9688.HK Zai Lab Limited
25.650
-1.16%